Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference85 articles.
1. Kahn, R. (2006). The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: Response to Citrome et al., Giugliano and Esposito, Cheta, and Psaty et al. Diabetes Care, 29(1), 177–178.
https://doi.org/10.2337/diacare.29.1.177-a
.
2. Engin, A. (2017). The definition and prevalence of obesity and metabolic syndrome. Obesity and Lipotoxicity Advances in Experimental Medicine and Biology, 1–17.
https://doi.org/10.1007/978-3-319-48382-5_1
.
3. Thorn, L. M., Forsblom, C., Waden, J., et al. (2009). Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care, 32(5), 950–952.
https://doi.org/10.2337/dc08-2022
.
4. Khan, Q. A., Sola, S., & Khan, B. V. (2006). The metabolic syndrome: Inflammation and endothelial dysfunction. Hospital Physician, 42, 26–37.
5. Preventing Chronic Disease. Centers for Disease Control and Prevention.
https://www.cdc.gov/pcd/issues/2017/16_0287.htm
. Published September 20, 2017. Accessed September 2, 2018.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献